Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Comment by whatyouthinkon Jun 22, 2009 4:17pm

377 Views

Post# 16089595

RE: RE: RE: Holding up well

I sleep well knowing we have a New Base around 0.14 - 0.15

Any one getting in under 0.20 is fine if they can afford to wait. Remember Theres…

The thing to keep in mind about SSS is this, on the stroke program alone there will be various key developments over the next several months as follows

1     Health Canada Approvals     soon
2     commencement of phase2b soon as well maybe sooner or early July latest
3     update on enrollment in phase 2b Sept
4     completion of enrollment Dec
5     disclosure of the results mar '09
6     start of phase 3 May - June ( fasttrack ? )

And don't forget to mention : Will move in US (Miami) next year, if I remember well :)

Cheers

Theres